All News

Much innovation has taken place in the field of minimally invasive gynecologic surgery in the last decade. Enthusiasm for single-port surgery has waned over the past decade, due to factors like Reimbursement issues and technical demand led to a decrease in enthusiasm, but robotics companies continue to develop new solutions.

While sacrocolpopexy has been the gold standard for the anatomical correction of pelvic organ prolapse for more than three decades, it is a technically challenging procedure that results in dividing the pelvis by mesh material and often requires extensive bowel manipulation.

Lactobacilli are the presiding members of the healthy human vaginal microbiota and are considered the first defense line from pathogen infection, including vulvovaginal candidiasis (VVC), whereas biofilm is the predominant microbial growth form in nature.

COVID-19 updates and news to know as of January 3, 2022.

A home kit to detect urinary tract infections (UTIs) like Candida albicans from vaginal fluids on sanitary napkins and tampons could soon enter the clinical phase.

The use of hair dyes, bleach, relaxers, and mousse was associated with lower levels of sex steroid hormones in pregnant women, according to a new Rutgers study.

A look at what's coming to Contemporary OB/GYN® this week

Women are less likely to be diagnosed with bladder cancer, but that does not make the disease any less fatal for this population of patients.

Each year, the Medical Economics® team surveys their audience to find out what big challenges practitioners faced. By far, the top answer was “administrative burdens,” including staffing, prior authorizations and electronic health records (EHRs). Let's take a closer look at what these burdens entail to help physicians get ready for whatever challenges 2022 will bring.

Researchers highlight the need for early interventions.

Pandemic’s impact could worsen gender divide in income and career prospects, study finds.

Two possible explanations for declining contentment with live video calls as a form of care delivery.

Apretude is approved for use in at-risk adults and adolescents to reduce the risk of sexually acquired HIV.

Investigators of the SWOG S1007 RxPONDER trial found a statistically significant improvement in invasive disease-free survival and distant relapse-free survival in premenopausal women who received adjuvant chemotherapy.

“I think discussing it and talking about the different techniques out there [is important],” says Svetlana Avulova, MD.

It's been a busy week for the Contemporary OB/GYN® team.

Contemporary OB/GYN® board members share their insights into the most influential articles of the year.

CDC data shown to overstate US vaccination rates; school-based cognitive behavioral therapy for overwhelmed children; Moderna to develop Omicron-specific COVID-19 booster dose.

Compared with tamoxifen, aromatase inhibitors were revealed to be more effective in reducing the rate of recurrence in ER+ breast cancer among premenopausal women receiving ovarian suppression.

The company says a third dose of their COVID-19 vaccine is effective against the latest variant of the disease.

Why text messaging is good for the business of health care

In using the biomarker approach to the treatment of triple-negative breast cancer, the challenge for the clinician is prioritizing the available treatment options based on the National Comprehensive Cancer Network guidelines for breast cancer, which focus on active agents, preferred single-agent chemotherapy approaches, and doublet options for certain patients at high risk.

Here's what's coming up this week on Contemporary OB/GYN®

Blood clot risk in J&J higher for women, draws CDC concerns

Take a look back at the top 10 women’s health news articles published on Drug Topics® this year.

The vaccine, which protects patients from seven different strains related to HPV-related cancers, may be considered part of routine oncology care for survivors.

Here's what you missed this week from Contemporary OB/GYN.

Many of the glaring disparities that exist in care for the 26 million women in the United States who suffer from uterine fibroids, which disproportionately affects up to 80% of Black women, are being aggressively addressed though a new multifaceted campaign called UNmuting Fibroids.